⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCTXZ News
BriaCell Therapeutics Corp. Warrant
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL